Multiple myeloma immunophenotype related to chromosomal abnormalities used in risk assessment

HIGHLIGHTS

• who: Mantas Radzeviu010dius and collaborators from the Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania have published the research: Multiple Myeloma Immunophenotype Related to Chromosomal Abnormalities Used in Risk Assessment, in the Journal: Diagnostics 2022, 12, x FOR PEER REVIEW Figure 2. 2. Significant Significant differences between different Revised-International StagFigure differencesininimmunophenotype immunophenotype between different Revised-International ing System (R-ISS) for multiple myeloma. MMPC-malignant plasma cells. MFI-mean fluorescence Staging System (R-ISS) for multiple myeloma. MMPC-malignant plasma cells. MFI-mean fluointensity.intensity . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.